Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Harvard Business School
Colorcon
Baxter
McKinsey

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

SODIUM NITROPRUSSIDE - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for sodium nitroprusside and what is the scope of freedom to operate?

Sodium nitroprusside is the generic ingredient in four branded drugs marketed by Roche, Abbott, Abbvie, Hospira, Abraxis Pharm, Akorn, Amneal Pharms Co, Amphastar Pharms Inc, Baxter Hlthcare, Cipla, Dr Reddys Labs Ltd, Medicure, Micro Labs, Mylan Labs Ltd, Nexus Pharms, Sagent Pharms Inc, Somerset Theraps Llc, Sun Pharm, Teva Parenteral, Virtus Pharm, and Exela Pharma Scs Llc, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and seventy-two drug master file entries for sodium nitroprusside. Twelve suppliers are listed for this compound.

Summary for SODIUM NITROPRUSSIDE
Recent Clinical Trials for SODIUM NITROPRUSSIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Penn State UniversityPhase 1/Phase 2
Colorado State UniversityEarly Phase 1
Cristália Produtos Químicos Farmacêuticos Ltda.Phase 4

See all SODIUM NITROPRUSSIDE clinical trials

Pharmacology for SODIUM NITROPRUSSIDE
Drug ClassVasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for SODIUM NITROPRUSSIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 209493-001 Nov 7, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 018581-001 Jul 28, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Virtus Pharm SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 209834-001 Jun 26, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Abraxis Pharm SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 070031-001 Jan 17, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Abbott NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 071555-001 Nov 16, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Johnson and Johnson
Express Scripts
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.